Combivent Respimat

  • Asthma/COPD

Combivent Respimat Generic Name & Formulations

General Description

Ipratropium bromide 20mcg, albuterol 100mcg (equivalent to 120mcg albuterol sulfate); per actuation; inhalation spray; CFC-free.

Pharmacological Class

Anticholinergic + beta-2 agonist.

How Supplied

Inhaler—4g (120 inh)

Generic Availability


Combivent Respimat Indications


COPD when a second aerosol bronchodilator is needed.

Combivent Respimat Dosage and Administration


1 inh 4 times daily; max 6 inh/day.


Not established.

Combivent Respimat Contraindications


Atropine allergy.

Combivent Respimat Boxed Warnings

Not Applicable

Combivent Respimat Warnings/Precautions


Avoid excessive use. Discontinue if paradoxical bronchospasm occurs. Cardiovascular disorders. Arrhythmias. Hypertension. Diabetes. Hyperthyroidism. Seizure disorders. Sensitivity to sympthomimetic amines. Narrow angle glaucoma. GI or GU obstruction. Hepatic or renal disease. Pregnancy. Labor & delivery. Nursing mothers: not recommended.

Combivent Respimat Pharmacokinetics

See Literature

Combivent Respimat Interactions


Extreme caution within 2 weeks of MAOIs or tricyclic antidepressants (increased cardiovascular effects). Caution with other anticholinergics, sympathomimetics, drugs that lower serum potassium. Antagonized by beta-blockers.

Combivent Respimat Adverse Reactions

Adverse Reactions

Upper respiratory infection, nasopharyngitis, cough, bronchitis, headache, dyspnea; paradoxical bronchospasm, urinary retention, hypokalemia, hypersensitivity reactions, ocular effects.

Combivent Respimat Clinical Trials

See Literature

Combivent Respimat Note

Not Applicable

Combivent Respimat Patient Counseling

See Literature